Associations	O
of	O
androgens	B:C0002844
with	O
depressive	O
symptoms	I:C0086132
and	O
cognitive	O
status	O
in	O
the	O
general	O
population	I:C0683971
Associations	O
between	O
androgens	O
and	O
depressive	O
symptoms	I:C0086132
were	O
mostly	O
reported	O
from	O
cross-sectional	O
and	O
patient	O
-	I:C0242481
based	I:C0242481
studies	I:C0242481
.	O

Associations	O
of	O
androgens	O
with	O
depressive	B:C0086132
symptoms	I:C0086132
and	O
cognitive	O
status	O
in	O
the	O
general	O
population	I:C0683971
Associations	O
between	O
androgens	O
and	O
depressive	O
symptoms	I:C0086132
were	O
mostly	O
reported	O
from	O
cross-sectional	O
and	O
patient	O
-	I:C0242481
based	I:C0242481
studies	I:C0242481
.	O

Associations	O
of	O
androgens	O
with	O
depressive	O
symptoms	I:C0086132
and	O
cognitive	O
status	O
in	O
the	O
general	B:C0683971
population	I:C0683971
Associations	O
between	O
androgens	O
and	O
depressive	O
symptoms	I:C0086132
were	O
mostly	O
reported	O
from	O
cross-sectional	O
and	O
patient	O
-	I:C0242481
based	I:C0242481
studies	I:C0242481
.	O

Associations	O
of	O
androgens	O
with	O
depressive	O
symptoms	I:C0086132
and	O
cognitive	O
status	O
in	O
the	O
general	O
population	I:C0683971
Associations	O
between	O
androgens	B:C0002844
and	O
depressive	O
symptoms	I:C0086132
were	O
mostly	O
reported	O
from	O
cross-sectional	O
and	O
patient	O
-	I:C0242481
based	I:C0242481
studies	I:C0242481
.	O

Associations	O
of	O
androgens	O
with	O
depressive	O
symptoms	I:C0086132
and	O
cognitive	O
status	O
in	O
the	O
general	O
population	I:C0683971
Associations	O
between	O
androgens	O
and	O
depressive	B:C0086132
symptoms	I:C0086132
were	O
mostly	O
reported	O
from	O
cross-sectional	O
and	O
patient	O
-	I:C0242481
based	I:C0242481
studies	I:C0242481
.	O

Associations	O
of	O
androgens	O
with	O
depressive	O
symptoms	I:C0086132
and	O
cognitive	O
status	O
in	O
the	O
general	O
population	I:C0683971
Associations	O
between	O
androgens	O
and	O
depressive	O
symptoms	I:C0086132
were	O
mostly	O
reported	O
from	O
cross-sectional	B:C0010362
and	O
patient	O
-	I:C0242481
based	I:C0242481
studies	I:C0242481
.	O

Associations	O
of	O
androgens	O
with	O
depressive	O
symptoms	I:C0086132
and	O
cognitive	O
status	O
in	O
the	O
general	O
population	I:C0683971
Associations	O
between	O
androgens	O
and	O
depressive	O
symptoms	I:C0086132
were	O
mostly	O
reported	O
from	O
cross-sectional	O
and	O
patient	B:C0242481
-	I:C0242481
based	I:C0242481
studies	I:C0242481
.	O

Longitudinal	O
data	O
from	O
4,110	O
participants	B:C0679646
of	O
the	O
Study	O
of	I:C0242481
Health	I:C0242481
in	O
Pomerania	O
were	O
used	O
to	O
assess	O
sex	O
-	O
specific	O
associations	O
of	O
baseline	O
total	O
and	O
free	O
testosterone	O
,	O
androstenedione	O
and	O
sex	O
hormone	I:C0036883
-	I:C0036883
binding	I:C0036883
globulin	I:C0036883
with	O
incident	O
depressive	O
symptoms	I:C0086132
and	O
cognitive	O
status	O
at	O
5	O
-	O
and	O
10	O
-	O
year	O
follow	O
-	I:C1522577
up	I:C1522577
.	O

Longitudinal	O
data	O
from	O
4,110	O
participants	O
of	O
the	O
Study	B:C0242481
of	I:C0242481
Health	I:C0242481
in	O
Pomerania	O
were	O
used	O
to	O
assess	O
sex	O
-	O
specific	O
associations	O
of	O
baseline	O
total	O
and	O
free	O
testosterone	O
,	O
androstenedione	O
and	O
sex	O
hormone	I:C0036883
-	I:C0036883
binding	I:C0036883
globulin	I:C0036883
with	O
incident	O
depressive	O
symptoms	I:C0086132
and	O
cognitive	O
status	O
at	O
5	O
-	O
and	O
10	O
-	O
year	O
follow	O
-	I:C1522577
up	I:C1522577
.	O

Longitudinal	O
data	O
from	O
4,110	O
participants	O
of	O
the	O
Study	O
of	I:C0242481
Health	I:C0242481
in	O
Pomerania	O
were	O
used	O
to	O
assess	O
sex	O
-	O
specific	O
associations	O
of	O
baseline	O
total	O
and	O
free	O
testosterone	B:C0039601
,	O
androstenedione	O
and	O
sex	O
hormone	I:C0036883
-	I:C0036883
binding	I:C0036883
globulin	I:C0036883
with	O
incident	O
depressive	O
symptoms	I:C0086132
and	O
cognitive	O
status	O
at	O
5	O
-	O
and	O
10	O
-	O
year	O
follow	O
-	I:C1522577
up	I:C1522577
.	O

Longitudinal	O
data	O
from	O
4,110	O
participants	O
of	O
the	O
Study	O
of	I:C0242481
Health	I:C0242481
in	O
Pomerania	O
were	O
used	O
to	O
assess	O
sex	O
-	O
specific	O
associations	O
of	O
baseline	O
total	O
and	O
free	O
testosterone	O
,	O
androstenedione	B:C0002860
and	O
sex	O
hormone	I:C0036883
-	I:C0036883
binding	I:C0036883
globulin	I:C0036883
with	O
incident	O
depressive	O
symptoms	I:C0086132
and	O
cognitive	O
status	O
at	O
5	O
-	O
and	O
10	O
-	O
year	O
follow	O
-	I:C1522577
up	I:C1522577
.	O

Longitudinal	O
data	O
from	O
4,110	O
participants	O
of	O
the	O
Study	O
of	I:C0242481
Health	I:C0242481
in	O
Pomerania	O
were	O
used	O
to	O
assess	O
sex	O
-	O
specific	O
associations	O
of	O
baseline	O
total	O
and	O
free	O
testosterone	O
,	O
androstenedione	O
and	O
sex	B:C0036883
hormone	I:C0036883
-	I:C0036883
binding	I:C0036883
globulin	I:C0036883
with	O
incident	O
depressive	O
symptoms	I:C0086132
and	O
cognitive	O
status	O
at	O
5	O
-	O
and	O
10	O
-	O
year	O
follow	O
-	I:C1522577
up	I:C1522577
.	O

Longitudinal	O
data	O
from	O
4,110	O
participants	O
of	O
the	O
Study	O
of	I:C0242481
Health	I:C0242481
in	O
Pomerania	O
were	O
used	O
to	O
assess	O
sex	O
-	O
specific	O
associations	O
of	O
baseline	O
total	O
and	O
free	O
testosterone	O
,	O
androstenedione	O
and	O
sex	O
hormone	I:C0036883
-	I:C0036883
binding	I:C0036883
globulin	I:C0036883
with	O
incident	O
depressive	B:C0086132
symptoms	I:C0086132
and	O
cognitive	O
status	O
at	O
5	O
-	O
and	O
10	O
-	O
year	O
follow	O
-	I:C1522577
up	I:C1522577
.	O

Longitudinal	O
data	O
from	O
4,110	O
participants	O
of	O
the	O
Study	O
of	I:C0242481
Health	I:C0242481
in	O
Pomerania	O
were	O
used	O
to	O
assess	O
sex	O
-	O
specific	O
associations	O
of	O
baseline	O
total	O
and	O
free	O
testosterone	O
,	O
androstenedione	O
and	O
sex	O
hormone	I:C0036883
-	I:C0036883
binding	I:C0036883
globulin	I:C0036883
with	O
incident	O
depressive	O
symptoms	I:C0086132
and	O
cognitive	O
status	O
at	O
5	O
-	O
and	O
10	O
-	O
year	O
follow	B:C1522577
-	I:C1522577
up	I:C1522577
.	O

Despite	O
sex	O
-	O
specific	O
differences	O
in	O
depressive	B:C0086132
symptoms	I:C0086132
prevalence	O
at	O
baseline	O
(	O
women	O
:	O
17.4	O
%	O
,	O
men	O
:	O
8.1	O
%	O
)	O
,	O
cross-sectional	O
analyses	I:C0010362
showed	O
no	O
associations	O
between	O
sex	O
hormones	O
and	O
depressive	O
symptoms	I:C0086132
.	O

Despite	O
sex	O
-	O
specific	O
differences	O
in	O
depressive	O
symptoms	I:C0086132
prevalence	O
at	O
baseline	O
(	O
women	B:C0043210
:	O
17.4	O
%	O
,	O
men	O
:	O
8.1	O
%	O
)	O
,	O
cross-sectional	O
analyses	I:C0010362
showed	O
no	O
associations	O
between	O
sex	O
hormones	O
and	O
depressive	O
symptoms	I:C0086132
.	O

Despite	O
sex	O
-	O
specific	O
differences	O
in	O
depressive	O
symptoms	I:C0086132
prevalence	O
at	O
baseline	O
(	O
women	O
:	O
17.4	O
%	O
,	O
men	B:C0025266
:	O
8.1	O
%	O
)	O
,	O
cross-sectional	O
analyses	I:C0010362
showed	O
no	O
associations	O
between	O
sex	O
hormones	O
and	O
depressive	O
symptoms	I:C0086132
.	O

Despite	O
sex	O
-	O
specific	O
differences	O
in	O
depressive	O
symptoms	I:C0086132
prevalence	O
at	O
baseline	O
(	O
women	O
:	O
17.4	O
%	O
,	O
men	O
:	O
8.1	O
%	O
)	O
,	O
cross-sectional	B:C0010362
analyses	I:C0010362
showed	O
no	O
associations	O
between	O
sex	O
hormones	O
and	O
depressive	O
symptoms	I:C0086132
.	O

Despite	O
sex	O
-	O
specific	O
differences	O
in	O
depressive	O
symptoms	I:C0086132
prevalence	O
at	O
baseline	O
(	O
women	O
:	O
17.4	O
%	O
,	O
men	O
:	O
8.1	O
%	O
)	O
,	O
cross-sectional	O
analyses	I:C0010362
showed	O
no	B:C1513916
associations	O
between	O
sex	O
hormones	O
and	O
depressive	O
symptoms	I:C0086132
.	O

Despite	O
sex	O
-	O
specific	O
differences	O
in	O
depressive	O
symptoms	I:C0086132
prevalence	O
at	O
baseline	O
(	O
women	O
:	O
17.4	O
%	O
,	O
men	O
:	O
8.1	O
%	O
)	O
,	O
cross-sectional	O
analyses	I:C0010362
showed	O
no	O
associations	O
between	O
sex	O
hormones	B:C0019932
and	O
depressive	O
symptoms	I:C0086132
.	O

Despite	O
sex	O
-	O
specific	O
differences	O
in	O
depressive	O
symptoms	I:C0086132
prevalence	O
at	O
baseline	O
(	O
women	O
:	O
17.4	O
%	O
,	O
men	O
:	O
8.1	O
%	O
)	O
,	O
cross-sectional	O
analyses	I:C0010362
showed	O
no	O
associations	O
between	O
sex	O
hormones	O
and	O
depressive	B:C0086132
symptoms	I:C0086132
.	O

In	O
age	O
-	O
adjusted	O
longitudinal	O
analyses	O
,	O
total	B:C0039601
testosterone	I:C0039601
was	O
associated	O
with	O
incident	O
depressive	O
symptoms	I:C0086132
(	O
relative	O
risk	O
at	O
5	O
-	O
year	O
follow	O
-	I:C1522577
up	I:C1522577
:	O
0.73	O
,	O
95	O
%	O
confidence	O
interval	O
:	O
0.58-0.92	O
)	O
.	O

In	O
age	O
-	O
adjusted	O
longitudinal	O
analyses	O
,	O
total	O
testosterone	I:C0039601
was	O
associated	O
with	O
incident	O
depressive	B:C0086132
symptoms	I:C0086132
(	O
relative	O
risk	O
at	O
5	O
-	O
year	O
follow	O
-	I:C1522577
up	I:C1522577
:	O
0.73	O
,	O
95	O
%	O
confidence	O
interval	O
:	O
0.58-0.92	O
)	O
.	O

In	O
age	O
-	O
adjusted	O
longitudinal	O
analyses	O
,	O
total	O
testosterone	I:C0039601
was	O
associated	O
with	O
incident	O
depressive	O
symptoms	I:C0086132
(	O
relative	O
risk	O
at	O
5	O
-	O
year	O
follow	B:C1522577
-	I:C1522577
up	I:C1522577
:	O
0.73	O
,	O
95	O
%	O
confidence	O
interval	O
:	O
0.58-0.92	O
)	O
.	O

Similarly	O
,	O
age	O
-	O
adjusted	O
analyses	O
showed	O
a	O
positive	B:C1446409
association	O
between	O
sex	O
hormone	I:C0036883
-	I:C0036883
binding	I:C0036883
globulin	I:C0036883
and	O
cognitive	O
status	O
in	O
men	O
(	O
β	O
-	O
coefficient	O
per	O
standard	O
deviation	O
:	O
0.44	O
,	O
95	O
%	O
confidence	O
interval	O
:	O
0.13-0.74	O
)	O
.	O

Similarly	O
,	O
age	O
-	O
adjusted	O
analyses	O
showed	O
a	O
positive	O
association	O
between	O
sex	B:C0036883
hormone	I:C0036883
-	I:C0036883
binding	I:C0036883
globulin	I:C0036883
and	O
cognitive	O
status	O
in	O
men	O
(	O
β	O
-	O
coefficient	O
per	O
standard	O
deviation	O
:	O
0.44	O
,	O
95	O
%	O
confidence	O
interval	O
:	O
0.13-0.74	O
)	O
.	O

Similarly	O
,	O
age	O
-	O
adjusted	O
analyses	O
showed	O
a	O
positive	O
association	O
between	O
sex	O
hormone	I:C0036883
-	I:C0036883
binding	I:C0036883
globulin	I:C0036883
and	O
cognitive	O
status	O
in	O
men	B:C0025266
(	O
β	O
-	O
coefficient	O
per	O
standard	O
deviation	O
:	O
0.44	O
,	O
95	O
%	O
confidence	O
interval	O
:	O
0.13-0.74	O
)	O
.	O

In	O
women	B:C0043210
,	O
age	O
-	O
adjusted	O
associations	O
of	O
androstenedione	O
with	O
baseline	O
depressive	O
symptoms	I:C0086132
(	O
relative	O
risk	O
:	O
0.88	O
,	O
95	O
%	O
confidence	O
interval	O
:	O
0.77-0.99	O
)	O
were	O
found	O
.	O

In	O
women	O
,	O
age	O
-	O
adjusted	O
associations	O
of	O
androstenedione	B:C0002860
with	O
baseline	O
depressive	O
symptoms	I:C0086132
(	O
relative	O
risk	O
:	O
0.88	O
,	O
95	O
%	O
confidence	O
interval	O
:	O
0.77-0.99	O
)	O
were	O
found	O
.	O

In	O
women	O
,	O
age	O
-	O
adjusted	O
associations	O
of	O
androstenedione	O
with	O
baseline	O
depressive	B:C0086132
symptoms	I:C0086132
(	O
relative	O
risk	O
:	O
0.88	O
,	O
95	O
%	O
confidence	O
interval	O
:	O
0.77-0.99	O
)	O
were	O
found	O
.	O

None	O
of	O
the	O
observed	O
associations	O
remained	O
after	O
multivariable	B:C0242481
adjustment	I:C0242481
.	O

The	O
present	O
population	B:C1709599
-	I:C1709599
based	I:C1709599
,	O
longitudinal	O
study	O
revealed	O
inverse	O
associations	O
between	O
sex	O
hormones	O
and	O
depressive	O
symptoms	I:C0086132
.	O

The	O
present	O
population	O
-	I:C1709599
based	I:C1709599
,	O
longitudinal	O
study	O
revealed	O
inverse	O
associations	O
between	O
sex	O
hormones	B:C0019932
and	O
depressive	O
symptoms	I:C0086132
.	O

The	O
present	O
population	O
-	I:C1709599
based	I:C1709599
,	O
longitudinal	O
study	O
revealed	O
inverse	O
associations	O
between	O
sex	O
hormones	O
and	O
depressive	B:C0086132
symptoms	I:C0086132
.	O

However	O
,	O
the	O
null	O
finding	O
after	O
multivariable	B:C0242481
adjustment	I:C0242481
suggests	O
,	O
that	O
the	O
observed	O
associations	O
were	O
not	O
independent	O
of	O
relevant	O
confounders	O
including	O
body	O
mass	I:C1305855
index	I:C1305855
,	O
smoking	O
and	O
physical	O
inactivity	O
.	O

However	O
,	O
the	O
null	O
finding	O
after	O
multivariable	O
adjustment	I:C0242481
suggests	O
,	O
that	O
the	O
observed	O
associations	O
were	O
not	O
independent	O
of	O
relevant	O
confounders	O
including	O
body	B:C1305855
mass	I:C1305855
index	I:C1305855
,	O
smoking	O
and	O
physical	O
inactivity	O
.	O

Furthermore	O
,	O
the	O
low	O
number	O
of	O
incident	O
endpoints	O
in	O
our	O
non-clinical	B:C0242481
population	I:C0242481
-	I:C0242481
based	I:C0242481
sample	I:C0242481
limited	O
the	O
statistical	O
power	I:C0814897
and	O
reduced	O
the	O
chance	O
to	O
detect	O
a	O
statistically	O
significant	O
effect	O
.	O

Furthermore	O
,	O
the	O
low	O
number	O
of	O
incident	O
endpoints	O
in	O
our	O
non-clinical	O
population	I:C0242481
-	I:C0242481
based	I:C0242481
sample	I:C0242481
limited	O
the	O
statistical	B:C0814897
power	I:C0814897
and	O
reduced	O
the	O
chance	O
to	O
detect	O
a	O
statistically	O
significant	O
effect	O
.	O

Furthermore	O
,	O
the	O
low	O
number	O
of	O
incident	O
endpoints	O
in	O
our	O
non-clinical	O
population	I:C0242481
-	I:C0242481
based	I:C0242481
sample	I:C0242481
limited	O
the	O
statistical	O
power	I:C0814897
and	O
reduced	O
the	O
chance	O
to	O
detect	B:C0442726
a	O
statistically	O
significant	O
effect	O
.	O

